Rhode Island Cholesterol Monitoring Rates Lagged

State clinicians failed to check cholesterol in 29% of visits for patients taking statins, a new study found.

Updated on Oct. 5, 2026 in Heart Disease

Bold flat-color editorial illustration featuring a medical vial and centrifuge tube rack, representing clinical cholesterol monitoring protocols.
A new national analysis reveals that Rhode Island clinicians failed to monitor cholesterol levels in 29% of visits for patients on statin therapy. AI Illustration. Upload story photo >

Live Poll

Do you trust your local doctors to consistently monitor your health metrics?

A new national analysis reveals that Rhode Island healthcare providers missed monitoring cholesterol levels during 29% of primary care visits for patients on statin therapy. This performance marks the third-highest failure rate in the country, significantly exceeding the national average of 17%.

Why it matters

Inadequate monitoring of cholesterol levels for patients on statins hinders the ability of doctors to ensure treatment efficacy and manage heart health. These gaps in care contribute to broader challenges in medication management, which carries a staggering annual cost to the U.S. health system.

The study analyzed 111,000 primary care visits to evaluate screening consistency. Nonadherence to medications and associated monitoring costs the U.S. health system $105.8 billion annually.

The players

Practicing Wisely

This is a clinical analytics system used to measure and report on healthcare delivery and quality standards across medical practices.

The details

The analysis utilized the Practicing Wisely clinical analytics system to track adherence to standard care protocols across the United States. While Rhode Island recorded a 29% failure rate, other states showed varying results, with Wyoming and Alaska reporting the highest rates of 32% and 30%, respectively, and South Carolina and Texas reporting the lowest at 14%.

Timeline

  1. September 29, 2026: Study results were released.

The Big Picture

This study follows the precedent set by the Practicing Wisely clinical analytics system to identify and quantify systemic gaps in primary care cholesterol monitoring.

Patients currently taking statins should consult with their primary care providers to ensure that regular cholesterol screenings are scheduled and documented. This proactive approach helps patients confirm that their current medication dosage remains effective in managing their heart health.

The takeaway

Consistent monitoring is essential for patients to safely manage cholesterol levels and reduce their cardiovascular risk. Ensuring that routine lab work is discussed during every office visit can lead to better long-term health outcomes and more effective therapy.

Further reading

For more information on improving cardiac outcomes, visit the Heart Disease section.

Source note: This article includes information reported by Providence Business News.

Live Poll

Do you trust your local doctors to consistently monitor your health metrics?